TriOptimize IX: Real-world improvement in COPD symptoms and lung function by extrafine singleinhaler triple therapy (efSITT)

被引：0
|
作者：
Trinkmann, F. [1 ]
Javan, S. Bahari [2 ]
Criee, C. [3 ]
Bogoevska, V [2 ]
Gessner, C. [4 ]
机构：
[1] Heidelberg Univ Hosp, Thoraxklin, Heidelberg, Germany
[2] Chiesi GmbH, Hamburg, Germany
[3] Evangelical Hosp Goettingen Weende, Bovenden, Germany
[4] Specialized Practice Pulm & Bronchial Med, Leipzig, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.1397
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1397
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical phenotyping in COPD patients treated with triple therapy and admitted to a rehabilitative center: a real-world retrospective study
    Vitacca, M.
    Salvi, B.
    Ceriana, P.
    Rizzello, L.
    Spanevello, A.
    Maniscalco, M.
    Balbi, B.
    Bruschi, C.
    De Nardi, P.
    Paneroni, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1975 - 1986
  • [33] Impact of extrafine single-inhaler triple therapy on treatment adherence after 6 months of treatment in asthmatics: a real-world view from Germany
    Trinkmann, Autoren F.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S36
  • [34] Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Nachtigall, D.
    Bogoevska, V
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S29 - S29
  • [35] Prescription Pathways from Initial Medication Use to Triple Therapy in Oder Individuals with COPD: A Real-World Population Study
    Gershon, A. S.
    Jiang, L.
    Tan, W-C
    Kendzerska, T.
    Stukel, T.
    Aaron, S. D.
    Pequeno, P.
    Stanbrook, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [36] Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study
    Jiang, Lili
    Kendzerska, Tetyana
    Aaron, Shawn D.
    Stukel, Therese A.
    Stanbrook, Matthew B.
    Tan, Wan
    Pequeno, Priscila
    Gershon, Andrea S.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 19 (01) : 315 - 323
  • [37] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
  • [38] Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy
    Palli, Swetha R.
    Frazer, Monica
    DuCharme, Mary
    Buikema, Ami R.
    Anderson, Amy J.
    Franchino-Elder, Jessica
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (10): : 1363 - 1374
  • [39] Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
    Pinto, Charleston
    Vale, Ana Carla
    Lauton, Priscila
    Costa, Lindemberg
    Lemos, Antonio Carlos
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [40] First Real-World Evidence on High Dose Strength of Extrafine Single-Inhaler Triple Therapy in Asthma Patients after Three Months of Treatment TriMaximize Study
    Gessner, C.
    Bogoevska, V
    Nachtigall, D.
    Akyildiz, B.
    Martini, M.
    Wendt, A.
    Criee, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
12345